Hemerion
Villeneuve · Founded 2020
About Hemerion
Hemerion is focused on creating innovative cancer treatments. The focus is on cutting-edge methods to treat glioblastoma, the most prevalent and dangerous primary brain tumour.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.9M
- Funding stage: Early Stage Venture
- Last round: Grant (May 2025)
- Website: https://hemerion.com/
Industries & Categories
Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/hemerion-84684 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.